Trial marks first-ever clinical study delivering two weeks of drug in a single oral dose Funded by a grant from the Bill & Melinda Gates Foundation, Lyndra answers World Health Organization’s call to investigate ivermectin as a new malaria eradication strategy WATERTOWN, Mass.–(BUSINESS WIRE)–Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a … [Read more…]

New blood tests aid in diagnosing systemic sclerosis and systemic lupus erythematosus PORTAGE, Mich.–(BUSINESS WIRE)–Thermo Scientific EliA RNA Pol III and EliA Rib-P tests have been cleared by the U.S. Food & Drug Administration (FDA) for aiding in the diagnosis of Systemic Sclerosis (SSc; scleroderma) and Systemic Lupus Erythematosus (SLE). With these new tests, the … [Read more…]

New service connects people online to reduce isolation and offer mental health support TORONTO–(BUSINESS WIRE)–LifeWorks, a world leader in providing in-person and digital solutions that support the mental health and total wellbeing of individuals, has launched LifeWorks Community worldwide – including in Canada, the United States, the United Kingdom, Australia and beyond. The program gives … [Read more…]

TORONTO–(BUSINESS WIRE)–The Ontario Bioscience Innovation Organization (OBIO®) and the City of Kawartha Lakes Family Health Team (CKL FHT) are launching a project in Ontario through OBIO’s Early Adopter Health Network (EAHN™) to improve the patient and provider experience, and enhance health outcomes via Goji Technology Systems’ innovative artificial intelligence (AI) virtual assistant platform, Goji Voice. … [Read more…]

LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #AlopeciaAreata—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate in a fireside chat at The JMP Securities Life Sciences Conference on June 16, 2022 at 1:00 p.m. ET in New York, NY. A webcast of the JMP fireside chat may be accessed in the Investors section of the Company’s website … [Read more…]

Strategic collaboration to further develop olamkicept highlights Ferring’s continued commitment to innovation in gastroenterology and inflammatory bowel disease. Olamkicept is the first and only clinical stage selective interleukin-6 (IL-6) inhibitor that works through the trans-signaling mechanism. IL-6 is associated with a number of inflammatory conditions, such as inflammatory bowel disease (IBD). SAINT-PREX, Switzerland–(BUSINESS WIRE)–#Ferring–Ferring Pharmaceuticals … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced that it will participate in a webinar on Unlocking the Value of Digital Prescription Therapeutics hosted by Cowen to discuss the recently released promising pivotal clinical … [Read more…]

Annual Meeting of Stockholders rescheduled to Thursday, July 28, 2022, 8:30 a.m. ET CLEVELAND–(BUSINESS WIRE)–$ATHX–Athersys, Inc. (Nasdaq: ATHX) today announced the postponement of its Annual Meeting of Stockholders, initially scheduled for Wednesday, June 15, 2022, at 8:30 a.m. ET. The Annual Meeting is now scheduled for Thursday, July 28, 2022, at 8:30 a.m. ET. The … [Read more…]

– Cemdisiran Treatment Resulted in a 37 Percent Mean Reduction in 24-Hour Urine Protein to Creatinine Ratio, Relative to Placebo – a Key Prognostic Marker of Progression to End-Stage Kidney Disease in Patients with IgA Nephropathy – – Acceptable Safety Profile, Supporting Continued Clinical Development – – Full Results to Be Presented at Future Medical … [Read more…]

GARDENA, Calif.–(BUSINESS WIRE)–#SpectrumbioCERTIFIED—Spectrum Chemical Mfg. Corp. (“Spectrum Chemical”), a leading global provider of fine chemicals, laboratory equipment and supplies, has entered into a new distribution arrangement with ANGUS Chemical Company (“ANGUS”) that expands Spectrum Chemical’s product offerings for research and development and production scale-up at commercial and academic organizations serving the biopharmaceutical and life sciences … [Read more…]